Transplant-related bronchiolitis obliterans

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:658602Y83.0
Who is this for?
Show terms as
3Active trials11Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Orphanet ↗NORD ↗

FDA & Trial Timeline

5 events
Jan 2026Mechanisms and Targeted Therapy of Airway Basal Cell Dysfunction in Bronchiolitis Obliterans Syndrome

Haikou Affiliated Hospital of Central South University Xiangya School of Medicine — NA

TrialENROLLING BY INVITATION
May 2023Evaluation of 3D Magnetic Resonance Spirometry: Comparison with Spirometry in Healthy Subjects and Patients with Respiratory Pathologies (asthma, COPD, Bilateral Lung Transplant)

Commissariat A L'energie Atomique — NA

TrialRECRUITING
Apr 2023Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

Renovion, Inc. — PHASE3

TrialRECRUITING
Nov 2020Cue Effects in Human Addiction: Pavlovian to Instrumental Transfer

Charite University, Berlin, Germany

TrialRECRUITING
Jan 2015Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts

Washington University School of Medicine — PHASE3

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Transplant-related bronchiolitis obliterans.

3 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

3 recruitingView all trials with filters →
Phase 32 trials
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
Phase 3
Actively Recruiting
PI: Tim Whelan, MD (Medical University of South Carolina) · Sites: Phoenix, Arizona; Los Angeles, California +18 more · Age: 1875 yrs
Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts
Phase 3
Active
PI: George J. Despotis, M.D. (Washington University St. Louis School of Medicine) · Sites: Birmingham, Alabama; Phoenix, Arizona +20 more · Age: 1899 yrs
N/A1 trial
Mechanisms and Targeted Therapy of Airway Basal Cell Dysfunction in Bronchiolitis Obliterans Syndrome
N/A
Enrolling by Invitation
PI: Xiaoyang Yang, DM (Department of Hematology, Haikou People's Hospital) · Sites: Haikou, Hainan

Specialists

11 foundView all specialists →
EM
EJ Kwak, MD
Specialist
PI on 1 active trial
XD
Xiaoyang Yang, DM
Haikou, Hainan
Specialist

Rare Disease Specialist

AM
Aldo T Iacono, MD
NEW HYDE PARK, NY
Specialist
PI on 2 active trials
MM
Michael Perch, MD
Specialist
PI on 1 active trial
GM
Greg Davis, MD
Specialist
PI on 1 active trial
ED
Emmanuel Yung, PT, DPT
Specialist
PI on 1 active trial
JP
Jean-Sébastien Roy, PT, PhD
Specialist
PI on 1 active trial
MP
Morris D Bell, PhD
Specialist
PI on 1 active trial
AM
Anne Dixon, MD
Specialist
PI on 1 active trial
SS
Stuart Sweet
SAINT LOUIS, MO
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Transplant-related bronchiolitis obliterans.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Transplant-related bronchiolitis obliteransForum →

No community posts yet. Be the first to share your experience with Transplant-related bronchiolitis obliterans.

Start the conversation →

Latest news about Transplant-related bronchiolitis obliterans

Disease timeline:

New recruiting trial: Evaluation of 3D Magnetic Resonance Spirometry: Comparison with Spirometry in Healthy Subjects and Patients with Respiratory Pathologies (asthma, COPD, Bilateral Lung Transplant)

A new clinical trial is recruiting patients for Transplant-related bronchiolitis obliterans

New recruiting trial: UTSW NORC Pilot Spinal Cord Injury Dietary Program

A new clinical trial is recruiting patients for Transplant-related bronchiolitis obliterans

New recruiting trial: Cue Effects in Human Addiction: Pavlovian to Instrumental Transfer

A new clinical trial is recruiting patients for Transplant-related bronchiolitis obliterans

New trial: Mechanisms and Targeted Therapy of Airway Basal Cell Dysfunction in Bronchiolitis Obliterans Syndrom

Phase NA trial recruiting. Bronchoscopic brushing

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Transplant-related bronchiolitis obliterans

Are there clinical trials for Transplant-related bronchiolitis obliterans?

Yes — 3 recruiting clinical trials are currently listed for Transplant-related bronchiolitis obliterans on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Transplant-related bronchiolitis obliterans?

11 specialists and care centers treating Transplant-related bronchiolitis obliterans are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.